An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution
Research · 01.01.2026 · 9
DOI: 10.34133/research.1257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research, online erschienen am 21.05.2026. Verfasst von Yaowei Li und 23 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150001,…. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of China.
Abstract (Originalsprache)
Renal metabolic behavior constitutes a critical evaluation parameter during drug development, toxicity assessment, and biodistribution. However, the inherent biological architecture of existing animal and cell-based models fails to recapitulate the authentic metabolic processes and spatial distribution patterns of drugs in the human kidney at a macroscopic level. Therefore, developing a standardized human-derived kidney model was necessary. In this work, the ex vivo tumor-bearing kidney (ETK) model was established using kidneys from 50 clinically diagnosed patients after the radical surgery. The standardized ETK model included the following: (a) selected according to the proportion of preserved normal tissue, vascular status suitable for ETK perfusion, and overall structural integrity of the kidneys; (b) surgical preparation exposed the renal pelvis and enabled catheterization of the renal artery and ureter; (c) perfused with hypothermic (4 to 10 °C) saline at a flow rate of 70 ml/min within perfusion system; and (d) ETK detection efficiency and drug biodistribution were assessed using biological sample indicators. Results showed that ETK maintained intact glomerular and tubular microstructures throughout perfusion and produced stable urine output with preserved filtration capacity. When treated with different kinds of nephrotoxic agents (cisplatin, gentamicin, and cephalosporins), the ETK model reproduced drug-specific injury patterns and exhibited biochemical changes and histological features that were consistent with real clinical observations. In drug-distribution analysis, indocyanine green (ICG) showed a negative fluorescence tumor contrast and enriched fluorescence in the normal kidney in the ETK model, which were consistent with real clinical observations, whereas mouse orthotopic renal cancer models showed positive ICG tumor accumulation, indicating species-dependent differences in renal drug distribution. Overall, the ETK model provided a structurally preserved and functionally responsive human-derived renal system for investigating renal drug metabolism, nephrotoxicity, tumor imaging, and drug-delivery strategies.
Autor:innen und Institutionen
- NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin 150001, China.
- Department of Urology, Harbin Medical University Cancer Hospital, Harbin 150001, China.
- Department of Urology, Second Affiliate Hospital of Harbin Medical University, Harbin 150001, China.
- Department of Cancer System Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
- Heilongjiang Provincial Key Laboratory of Basic Medical Sciences in Urology Cancer, Harbin Medical University Cancer Hospital, Harbin 150001, China.
- Biobank, Harbin Medical University Cancer Hospital, Harbin 150001, China.
ORCID-Profile: Yaowei Li, Qi Liu, Ziyi Liu, Haonan Li, Haiqiang Duan, Shiyu Huang, Qing Shi, Yubo Zhao, Tianxi Yu, Guangzheng Wu, Hongjian Song, Yishuo Yan, Zhishuai Zhang, Zongzheng Yang, Zhihao Yin, Jianwei Wang, Peng Zhang, Peng Dai, Dayong Hou, Zhichao Tong, Ziqi Wang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of China
- Heilongjiang Province Key Research & Development Program
- Key Research and Development Project of Heilongjiang Province
- The Key Research and Development Program of Heilongjiang Province
- Key Research and Development Program of Heilongjiang Province
- Nn10 project at the Affiliated Cancer Hospital of Harbin Medical University
Zitieren
APA
Li, Y., Wang, Z., Liu, Q., Liu, Z., Li, H., Duan, H., Huang, S., Shi, Q., Zhao, Y., Xu, J., Yu, T., Wu, G., Song, H., Zhao, C., Yan, Y., Zhang, Z., Yang, Z., Yin, Z., Wang, J., …, & Wang, Z. (2026). An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution. Research, 9. https://doi.org/10.34133/research.1257
Vancouver
Li Y, Wang Z, Liu Q, Liu Z, Li H, Duan H, et al. An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution. Research. 2026;9. doi:10.34133/research.1257
BibTeX
@article{Li2026,
author = {Li, Yaowei and Wang, Zhe and Liu, Qi and Liu, Ziyi and Li, Haonan and Duan, Haiqiang and Huang, Shiyu and Shi, Qing and Zhao, Yubo and Xu, Jiaqian and Yu, Tianxi and Wu, Guangzheng and Song, Hongjian and Zhao, Changhao and Yan, Yishuo and Zhang, Zhishuai and Yang, Zongzheng and Yin, Zhihao and Wang, Jianwei and Zhang, Peng and Dai, Peng and Hou, Dayong and Tong, Zhichao and Wang, Ziqi},
title = {An Ex Vivo Patient-Derived Tumor-Bearing Human Kidney Model Recapitulates Drug Toxicity and Metabolic Distribution},
journal = {Research},
year = {2026},
volume = {9},
doi = {10.34133/research.1257}
}
EUVIMED